Skip to main content

NL
FR
EN

Other information and services: www.belgium.be Logo of the Belgian Federal Authorities

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Search

Home
Human use
Veterinary use
Information for the public
Information for professionals

Home
Human use
Medicines
Current Page:Medicines

Medicines

COVID-19
- Research and development
- Vaccines
Scientific-technical advice
- Introduction
- Procedures
- Regulation
- Fees
- FAQ's
- Statistics
National Innovation Office
Research & Development
Marketing Authorisation procedures
Pharmacovigilance
Production
Distribution & Delivery
Autorisations - certificates
Declarations - Registrations
Proper use of medicine

Last updated on 16/12/2020

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

15/01/2021

Influenza vaccine: vaccination of at-risk groups completed, vaccine can be delivered to people of low-risk groups

14/01/2021

Coronavirus: weekly overview of 14 January 2021 on adverse reactions of COVID-19 vaccines

13/01/2021

Amended legislation: drug precursors added to list of scheduled substances

13/01/2021

Flash VIG-news: Metamizole (NOVALGINE): information on the risks of liver injuries and pharmacokinetic interactions

© 2016 - FAMHP

202030
202030
CUP202027
Disclaimer

instructions how to enable JavaScript in your web browser